Rifaximin in treatment of recurrent Clostridium difficile-associated diarrhea: an uncontrolled pilot study

J Clin Gastroenterol. 2009 Jan;43(1):91-3. doi: 10.1097/MCG.0b013e31814a4e97.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Aged
  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / therapeutic use*
  • Clostridioides difficile / drug effects
  • Clostridioides difficile / isolation & purification
  • Clostridium Infections / drug therapy*
  • Clostridium Infections / microbiology
  • Diarrhea / drug therapy*
  • Diarrhea / microbiology
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Pilot Projects
  • Recurrence
  • Rifamycins / adverse effects
  • Rifamycins / therapeutic use*
  • Rifaximin

Substances

  • Anti-Bacterial Agents
  • Rifamycins
  • Rifaximin